Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma-Reference-Cited by-同舟云学术

Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma

Published:2016-12 Issue: Volume:51 Page:41-48
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Burnworth Bettina,Wang Zhixing,Singleton Timothy P.,Bennington Angela,Fritschle Wayne,Bennington Richard,Brodersen Lisa Eidenschink,Wells Denise A.,Loken Michael R.,Zehentner Barbara K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference46 articles.

1. Lymphoplasmacytic lymphoma;Swerdlow,2008

2. Pathophysiology of Waldenstrom's macroglobulinemia;Stone;Haematologica,2010

3. How to manage Waldenstrom's macroglobulinemia;Buske;Leukemia,2013

4. Defining Waldenstrom's macroglobulinemia;Treon;Semin. Oncol.,2003

5. Report of the Third International Workshop on Waldenstrom's macroglobulinemia;Treon;Clin. Lymphoma,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions;Frontiers in Oncology;2023-03-23

2. Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance;Diagnostics;2022-04-12

3. Premalignant Clonal Hematopoietic Proliferations;American Journal of Clinical Pathology;2019-07-15

4. Molecular Diagnostics for Minimal Residual Disease Analysis in Hematopoietic Malignancies;Minimal Residual Disease Testing;2018-11-16

5. Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies;Leukemia;2018-07-19